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ABSTRACT
Premature translation-termination codons (PTCs)
elicit rapid degradation of the mRNA by a process
called nonsense-mediated mRNA decay (NMD).
NMD appears to be significantly more efficient for
mRNAs of genes belonging to the immunoglobulin
superfamily, which frequently acquire PTCs during
VDJ rearrangment, than for mRNAs of other genes.
To identify determinants for efficient NMD, we devel-
oped a minigene system derived from a mouse
immunoglobulin m gene (Ig-m) and measured the
effect of PTCs at different positions on the mRNA
level. This revealed that PTCs located downstream
of the V–D junction in the VDJ exon of Ig-m minigenes
and of endogenous Ig-m genes elicit very strong
mRNA downregulation, whereas NMD efficiency
decreases gradually further upstream in the V seg-
ment where a PTC was inserted. Interestingly, two
PTCs are in positions where they usually do not
trigger NMD (,50 nt from the 30-most 50 splice site)
still resulted in reduced mRNA levels. Using a set of
hybrid constructs comprised of Ig-m and an inefficient
substrate for NMD, we identified a 177 nt long ele-
ment in the V segment that is necessary for efficient
downregulation of PTC-containing hybrid tran-
scripts. Moreover, deletion of this NMD-promoting
element from the Ig-m minigene results in loss of
strong NMD.
INTRODUCTION
Quality control mechanisms at different steps of gene expres-
sion are important to prevent accumulation of malfunctioning,
deleterious proteins in a cell. On the post-transcriptional level,
eukaryotic cells possess a translation-dependent quality
control system referred to as nonsense-mediated mRNA
decay (NMD) or mRNA surveillance that recognizes aberrant
mRNAs with premature translation-termination codons
(PTCs) and selectively degrades these nonsense mRNAs
(1–5). By reducing the steady-state levels of PTC-containing
mRNA (hereafter called as PTC+ mRNA), NMD prevents
accumulation of C-terminally truncated proteins, which
are toxic for cells when they act as dominant-negative
inhibitors of the wild-type (wt) protein. Therefore, NMD
plays a vital role in improving the fidelity of gene
expression to the level required for complex organisms to
function properly.
But what are the rules for deciding whether a translation-
termination codon is premature (i.e. a PTC) or whether it is the
correct physiological stop codon? Analysis of mRNA levels
from triose phosphate isomerase (TPI), mouse major urinary
protein (MMUP), glutathione peroxidase 1 (GPx1) and
b-globin genes with PTCs at many different positions revealed
that only stop codons located more than 50–55 nt upstream of
the 30-most exon-exon junction mediate a reduction in mRNA
abundance (6–10). This ‘50 nucleotides boundary rule’ for
NMD is corroborated further by the finding that nearly all
physiological stop codons in the mRNAs of a variety of organ-
isms reside either in the last exon or within the 30-most 50 nt of
the second-last exon (11). It was subsequently discovered that
the exon junction complex (EJC), a protein complex that is
deposited on the mRNA during splicing 22 nt upstream of
the exon-exon junction (12,13), provides a binding platform
for NMD factors (14). Based on these findings, the current
mechanistic models for NMD in mammals (15–18) propose
that the ribosome displaces or modifies all EJCs upstream of
the stop codon during the first round of translation. It is pos-
tulated further that, if there remains a (unmodified) EJC on the
mRNA downstream of the stop codon, an interaction between
the terminating ribosome and this EJC triggers rapid degrada-
tion of the mRNA by an hitherto not known mechanism.
Among the relatively small number of genes for which the
effects of PTCs has been systematically investigated, tran-
scripts encoded by genes of the immunoglobulin superfamily
differ remarkably from transcripts of other genes in several
aspects. For example, steady-state levels of PTC+ T-cell
receptor b (TCR-b) transcripts, as well as of PTC+ transcripts
encoding immunoglobulin heavy and light chains, are down-
regulated several fold more efficiently than for example PTC+
b-globin or TPI mRNAs (19). Because PTCs arise very fre-
quently in TCR and immunoglobulin genes as a consequence
of programmed V(D)J rearrangements during lymphocyte
maturation, whereas somatic mutation leading to PTCs
in other genes is relatively a rare event, it is conceivable
that specific signals might have evolved in genes of the
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immunoglobulin superfamily that trigger a particularly effi-
cient mode of NMD to avoid production of truncated TCR and
immunoglobulin polypeptide chains. In support of this hypoth-
esis, the VDJ exon together with immediately flanking intron
sequences of two differently rearranged TCR-b genes have
recently been shown to elicit strong downregulation when
inserted into a PTC+ TPI gene (19).
TCR-b transcripts also differ from other mammalian mRNAs
in that they violate the ‘50 nucleotides boundary rule’. TCR-b
mRNAs with PTCs closer than 50 nt to the 30-most exon–exon
junction are still downregulated, although less efficient than
TCR-b mRNAs with PTCs upstream of the boundary (20,21).
This indicates that there may exist different modes by which
PTCs can decrease steady-state mRNA levels.
To investigate further these extraordinary effects of PTCs
on transcripts of the immunoglobulin superfamily, we have
developed an Ig-mminigene system and analyzed the effects of
PTCs at many different positions on steady-state mRNA
levels. We find that only PTCs located downstream of the
V-D junction in the VDJ exon can cause a strong downregula-
tion in the mRNA levels, whereas the extent of mRNA down-
regulation gradually decreases further upstream where the
PTC is located in the V segment. Remarkably and like
TCR-b, Ig-m transcripts do not comply with the ‘50 nucleo-
tides boundary rule’. Furthermore, a 177 nt long sequence
element comprising the 50-half of the VDJ exon could be
identified that is necessary for strong downregulation of
PTC+ mRNA.
MATERIALS AND METHODS
Cell lines and plasmids
Mouse Ig-m hybridoma cell lines used in this study are
described in (22). The Ig-m minigene is derived from the
plasmid pR-Sp6 described in (23). The intron between VDJ
and C1 exons was shortened by fusing the 5
0 part of the Ig-m
gene (comprising the VL and VDJ exon, from the translation
start codon to 32 nt downstream of the VDJ 50 splice site) to the
30 part of the Ig-m gene (comprising the exons C1–C4, starting
from 281 nt upstream of the exon C1 3
0 splice site). Exact
sequences of all constructs are available on request. Non-
sense and frameshift mutations in the Ig-m minigene were
generated by PCR-mediated site-directed mutagenesis using
‘QuikChange1 XL Site-Directed Mutagenesis Kit’ (Strata-
gene). Oligonucleotide sequences used are available on
request. PTCs at amino acid positions 32, 57, 73, 310, 440,
452 and 459 were generated by mutations of AAG to TAG
(construct Ter32), AAG to TAG (construct Ter57), GGA to
TGA (construct Ter73), GGA to TGA (construct Ter310),
GAA to TAA (construct Ter440), TCA to TGA (construct
Ter452) and TCA to TGA (construct Ter459), respectively.
Construct Ter108 was obtained by insertion of an adenosine
between codon 104 and 105, generating a 1 frameshift. The
Sxl minigene comprising exons 2–4 is based on the
TE23430sspCA sequence described in (24), which contains
two PTCs at amino acid positions 43 and 47 in exon3. The
two PTCs were changed into Trp and Gln by site-directed
mutagenesis using ‘QuikChange1 Site-Directed Mutagenesis
Kit’ (Stratagene). To keep the open reading frame (ORF) in the
hybrid constructs intact, the third nucleotide (guanosine)
upstream of the Sxl exon 2 50 splice site was deleted, and a
guanosine, one nucleotide after the Sxl exon 3 30 splice site was
inserted. The various deletions of parts of the Ig-m VDJ exon
were generated by fusion PCR. The 177 bp seq-
uence comprising the NPE was amplified using primers
50-GACTCCCGGGACTGCCAGGTCCAGCTGCAG-30 and
50-GACTCCCGGGTATTAACATTTCCAGGATAAATCC-
ATC-30 (Ava1 site in italics), or primers 50-CTGCAGAA-
CCATCCCAATGGCTGCCAGGTCCAGCTGCAG-30 and
50-CTGCAGAACCATTGGGATGGGTATTAACATTTCC-
AGGATAAATCCATC-30 (BstX1 site in italics), and inserted
into the Ava1 or BstX1 site of minimDNPE to generate mini-
mDNPE/NPEC1 and minimDNPE/NPEC3, respectively. The
coding parts and any other relevant parts of all constructs
used in this study were verified by sequencing.
Cell culture and transfection
HeLa cells were grown in Dulbecco’s modified Eagle’s med-
ium (DMEM, Invitrogen), supplemented with 10% heat-inac-
tivated fetal calf serum (FCS), 100 U/ml penicillin and 100 mg/
ml streptomycin (Amimed).
HeLa cells were grown in 6-well plates and transfected at a
confluency of 80% with 100 ng plasmid DNA, using 3 ml
LipofectAmine (Invitrogen). In transient transfection experi-
ments, cells were harvested 48 h post transfection. Polyclonal
populations of stably transfected HeLa cells were obtained by
selection with 500 mg/ml G418 (Roche) for 2–3 weeks. The
results from stably transfected polyclonal cell pools have been
reproduced for each construct with at least two independently
transfected cell pools.
Real-time RT–PCR
Total cellular RNA (1 mg) isolated with ‘Absolutely RNATM
RT–PCR Miniprep Kit’ (Stratagene) was reverse transcribed
in 50 ml Stratascript first strand buffer in the presence of 0.4 mM
dNTPs, 300 ng random hexamers, 40 U RNasIn (Promega) and
50 U Stratascript (Stratagene) according to the manufacturer’s
protocol. For real-time PCR, reverse transcribed material corre-
sponding to 40 ng RNA was amplified in 30 ml Universal
PCR Master Mix, No AmpErase1 UNG (Applied Biosystems)
and with the primers and TaqMan probes described below.
Ig-m mRNA and mRNA of hyb3 was measured over the
exonC2/exonC3 junction with 800 nM 5
0-GTCTCACCTTC-
TTGAAGAACGTGTC-30, 800 nM 50-GGGATGGTGAA-
GGTTAGGATGTC-30 and 200 nM 50-FAM-CACATGTG-
CTGCCAGTCCCTCCAC-TAMRA-30. Sxl mRNA and
mRNA of hyb4, hyb6 and hyb8-14 was measured over the Sxl
exon 3/exon 4 junction using 400 nM 50-TTTGAATCGAGGA-
CACCTCCA-30, 400 nM 50-TGGCAGAGAATGGGACA-
TCC-30 and 200 nM 50-FAM-AGCCCTTGGTGGGCGTGG-
ATTT-TAMRA-30. Neo mRNA was measured using 800 nM
50-TGTGACATAATTGGACAAACTACCTACA-30, 800 nM
50-CATTCCACCACTGCTC-CCA-30 and 200 nM 50-FAM-
AGATTTAAAGCTCTAAG-ATTCCAACCTATGGAACT-
GATGATAMRA-30. GAPDH mRNA and 18S rRNA were
measured using pre-developed assay reagents from Applied
Biosystems.For18SrRNAmeasurements,400pgcDNAinstead
of 40 ng was used. Real time PCR was run on the GeneAmp
5700 Sequence Detection System (Applied Biosystems) using
the standard thermal profile.
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Northern blot analysis
Total cellular RNA (15 mg) was separated on a 1.2% agarose
gel containing 1· MOPS and 1% formaldehyde. RNA
was transferred to positively charged nylon membranes
(Roche) in 20· SSC by standard capillary blotting method.
Following UV crosslinking of the RNA to the nylon filter,
pre-hybridization and hybridization were carried out in
6· SSC, 5· Denhardt’s reagent and 0.5% SDS at 60C.
Pre-hybridization was with 50 mg/ml denatured herring
sperm DNA and 100 mg/ml denatured calf thymus DNA.
For hybridization, 100 ng hyb4+ or minim ter310 DNA was
labeled with [a-32P]dCTP using the Ready-To-GoTM DNA
labeling Kit (Amersham). After overnight hybridization,
membranes were washed twice with 2· SSC/0.2% SDS and
twice with 0.2· SSC/0.1% SDS at 60C before exposure to a
PhosphorImager screen.
RT–PCR
Total cellular RNA was isolated and reverse transcribed as for
real-time RT–PCR, except that 6 ng/ml of oligo 50-(dT)30VN-30
or 244 nM of reverse primer 50-CAGTTGCTCACG-
AGCTGGTGGC-30 was used instead of random hexamers.
Reverse transcribed material corresponding to 100 ng RNA
was amplified with ‘PCR Core Kit’ (Qiagen) in 50 ml PCR
buffer containing 200 nM dNTPs, 5 U Taq polymerase and 244
nM forward (50-GGCTAGTGTTTGTGTGGAAGACTGGA-
ATAAC-30) and reverse primer to analyze the C3/C4 region.
RT–PCR (10 ml) reaction was separated on a 2% agrose gel,
and the rest was used to clone into the TOPO vector pCRII
(Invitrogen) for subsequent sequencing. For TOPO cloning of
the Vleader/VDJ/C1 region in minimwt and minimDNPE
mRNA, cDNA was amplified using 300 nM of primers
50-ACTGCATTGTCGACCTCACCATGGGATGGAG-30 and
50-AGCGCCTAGGGAGGTGGCTAGGTACTTGCCCCCTG-30.
Western blot analysis
Whole cell lysates were electrophoresed on a 10% SDS-
PAGE. Protein was transferred to Optitran BA-S 85 reinforced
nitrocellulose (Schleicher & Schuell) and probed with a 1:500
dilution of affinity-purified goat anti-mouse IgM (m chain-
specific, Jackson ImmunoResearch Laboratories). The
primary antibody was detected with a 1:4000 diluted horsera-
dish peroxidase-conjugated donkey anti-goat IgG antibody
(Promega) using ECL+ western blotting detection system
(Amersham Pharmacia Biotech).
RESULTS
Efficiency of NMD increases with 50 to 30 polarity
For studying in more detail effects of premature termination
codons (PTCs) on stability (NMD) and on splicing (NAS) of
Ig-m transcripts, a minigene construct was derived from the
productively rearranged mouse Ig-m gene expressed in the
hybridoma cell line Sp6 (23), which produces IgM against
the hapten 2,4,6-trinitrophenyl (25). The Ig-m minigene
comprises the leader exon, the VDJ exon and the four
exons of the constant region (C1–C4), but lacks the two
final exons (M1 and M2) that encode the membrane-binding
domain of the heavy chain (Figure 1A). The 5.7 kb long
intron between the VDJ and the C1 exon of the endogenous
gene was shortened to 307 bp, thereby deleting the m enhancer
and flanking matrix attachment regions. In the expression
vector, the Ig-m minigene is transcribed from the human
b-actin promoter. To investigate the efficiency of NMD eli-
cited by PTCs at different positions, Ig-m minigene constructs
with a PTC at amino acid positions 32, 57, 73, 108 and 310
were generated by site-directed mutagenesis (Figure 1A).
Relative mRNA levels of these constructs expressed in
HeLa cells after transient (Figure 1B and C) or stable trans-
fection (Figure 1D) were measured by real-time PCR using
TaqMan chemistry and analyzed by northern blotting (Figure
1C and data not shown). Irrespectively whether relative Ig-m
mRNA levels were determined from transient transfections by
normalizing to plasmid-encoded neomycin mRNA (Figure
1B) or from stably transfected polyclonal cell pools by nor-
malizing to endogenous GAPDH mRNA (Figure 1D), the
result was very similar, demonstrating that the stably trans-
fected cell pools represent true polyclonal ‘average popula-
tions’. The northern blots confirmed that all constructs
produced one major mRNA species of the expected size.
Over all, the pattern of mRNA reduction in response to a
PTC is very similar in the minigene system (Figure 1B–D)
and in the hybridoma cells that express from the endogenous
promoter the full-length Ig-m gene with PTCs at different
positions (Figure 1E).
In comparison to other well-studied NMD substrates, PTC+
transcripts of TCR-b, Ig-k and Ig-m genes are in general down-
regulated much more efficiently (19). Here, we find that the
mRNAs of Ig-m minigenes expressed in HeLa cells under the
control of the b-actin promoter are as efficiently downregu-
lated as the endogenous Ig-m mRNAs in the hybridoma cells
with a PTC at a corresponding position, suggesting that all
signals for efficient downregulation reside in the mRNA and
that neither the promoter nor the cell type significantly influ-
ences the efficiency of Ig-m NMD. Most interestingly, the
efficiency of NMD depends on the position of the PTC and
increases as the PTC is moved further downstream in the Ig-m
gene, as reflected by the decreasing PTC+ mRNA levels. This
50 to 30 polarity of NMD efficiency was apparent irrespectively
of whether the constructs were transiently transfected (Figure
1B) or whether mRNA of polyclonal populations of stably
transfected cells was analyzed (Figure 1D). The same 50 to
30 polarity of NMD efficiency was also observed in Sp6-
derived hybridoma cell lines expressing Ig-m genes with
PTCs at different positions (22,26). In these cells, the
mRNA level of a Ig-m gene with a PTC at amino acid position
3 (cell line N89) is only 2-fold lower compared with the wt
Ig-m mRNA (cell line Sp6), whereas a PTC at amino acid
position 73 (cell line N114) results in a 10-fold reduction
of mRNA. PTCs further downstream in the Ig-m gene at
amino acid positions 325 and 335 (cell lines X54 and U30,
respectively) reduced the mRNA level even further to 3.1 and
5.4% of wt Ig-m mRNA, respectively. Cell line X10 has
the Ig-m gene deleted and serves as a negative control.
Collectively, our results suggest that only PTCs located
downstream from the middle of the VDJ exon have the
capacity to elicit maximal Ig-m mRNA downregulation
(see also below).
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Testing the ‘50 nucleotides boundary rule’ for
PTC+ Ig-m transcripts
To examine whether PTC+ Ig-m mRNA also conforms to the
‘50 nucleotides boundary rule’ (11), we determined mRNA
levels of stably or transiently transfected Ig-m minigene con-
structs with a PTC 67 (Ter440), 31 (Ter452) or 10 nt (Ter459)
upstream of the 30-most exon–exon junction (Figure 2 and data
not shown). Ter440 mRNA (Figure 2B) was reduced to a
similar extent as Ter73, Ter108 and Ter310 mRNA (Figure
1D), indicating that NMD is still fully functioning just
upstream of the ‘50 nucleotides boundary’. When the PTC
is located closer than 50 nt to the 30-most exon–exon junction
(Ter452 and Ter459), the mRNA is still downregulated about
3-fold compared with wt Ig-m mRNA. Thus, Ig-m shows an
intermediate phenotype with regard to the ‘50 nucleotides
Figure 1. Efficiency of NMD increases with 50 to 30 polarity. (A) Schematic representation of the Ig-m gene, with numbers above depicting the amino acid positions
where PTCs were inserted in the m-minigene. The position of the PTC in the endogenous Ig-m gene in the different hybridoma cell lines is shown below the diagram.
The original clone names of the hybridoma cell lines are used throughout this paper (22). The PTC in cell line N89, N114, X54 and U30 is located at amino acid
positions 3, 73, 325 and 335, respectively. (B) Relative Ig-mmRNA levels of HeLa cells transiently transfected with the indicated Ig-mminigenes under control of the
human b-actin promotor were analyzed 48 h post transfection by real-time RT–PCR. The indicated relative Ig-mmRNA levels were normalized to neomycin mRNA
encoded on the transfected plasmid. ‘wt’ denotes the PTC-free Ig-mminigene, the various PTC+ constructs are named ‘Ter’ (for termination) followed by a number
indicating the amino acid position of the PTC. (C) Analysis of the same RNA used in (B) by northern blotting using a 32P-labeled probe for Ig-mmRNA. As a loading
control, the 18S rRNA band from the ethidium bromide-stained gel before blotting is shown in the lower panel. (D) HeLa cells were transfected with the same Ig-m
minigene constructs as in (B) and stably transfected polyclonal cell pools were generated by selection with Geneticin. Relative Ig-mmRNA levels were determined by
real-time RT–PCR as in (B) and normalized to relative endogenous GAPDH mRNA levels. (E) RNA of the parental hybridoma cell line Sp6, encoding a productively
rearranged full-length Ig-mmRNA, and of five Sp6-derived, mutated cell clones was analyzed. X10 has deleted the entire Ig-m gene and serves as a negative control.
Relative Ig-mmRNA levels were determined by real-time RT–PCR as in (B) and normalized to relative 18S ribosomal RNA levels. In (B), (D) and (E), average values
of three real-time PCR runs with cDNAs of one representative experiment are shown. Error bars indicate standard deviations.
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boundary’: on the one hand, the 3-fold reduced mRNA levels
of Ter452 and Ter459 represent a clear violation of the bound-
ary rule. For comparison, in b-globin, TPI, MMUP or GPx1,
PTCs downstream of the boundary do not reduce mRNA
levels at all (6,7,10,27). On the other hand, Ter452 and
Ter459 mRNA levels are downregulated about 4- to 5-fold
less than Ter440 mRNA, indicating that the ‘50 nucleotides
boundary’ nevertheless has an effect on Ig-m mRNAs (see
Discussion). Northern blot analysis confirmed that the point
mutations introduced to generate the PTCs did not cause large
alterations of the splicing pattern of the transcripts (Figure
2C). To exclude that the mutations close to the 50 splice
site activated a cryptic 50 splice site nearby, we examined
this region of the transcripts also by RT–PCR. As shown in
Figure 2D, the three nonsense mRNAs and the wt Ig-m mRNA
all gave an amplification product corresponding in length to
the 163 bp predicted for the correct removal of the C3/C4
intron. Correct joining of exons C3 and C4 during splicing
was further confirmed by cloning and sequencing of the RT–
PCR products (data not shown).
The 50 half of the Ig-m VDJ exon is essential for strong
mRNA downregulation of PTC+ hybrid constructs
As mentioned above, TCR-b and immunoglobulin transcripts,
which commonly harbor PTCs as a result of programmed
DNA rearrangement during lymphocyte maturation, are down-
regulated much more effectively in response to PTCs than
other known mammalian gene transcripts. This efficient
mRNA downregulation appears to depend on signals encoded
within the RNA (19). To identify sequence elements that
influence the efficiency of PTC+ mRNA downregulation,
hybrid genes were generated between sequences of the Ig-m
minigene and of a Drosophila Sex-lethal (Sxl) minigene. The
Sxl minigene used here comprises exons 2–4 of the Sxl gene
and is derived from TE234 30ss pCA (24), which contains a
mutation in the proximal 30 splice site of exon 3 and therefore
exclusively uses the distal 30 splice site of exon 3 (24). Nota-
bly, this Sxl minigene lacks the sequences that code for the
RNA binding domain present in the female-specific functional
Sxl protein. Thus, neither the PTC+ nor the PTC-version can
interfere with its own pre-mRNA splicing. In HeLa cells,
because of the absence of functional Sxl protein, the PTC-
containing male-specific exon 3 is always included in the
Sxl mRNA. Compared with a construct where the two in-
frame stop codons in exon 3 (ter43 and ter47) were removed,
the PTC+ Sxl mRNA was downregulated only about 3-fold. In
contrast, PTC+ Ig-m transcripts were downregulated more than
20-fold (Figures 1 and 3A).
For the first hybrid constructs, we fused the 50 half of the
Ig-m minigene (VL and VDJ exons) with the 30 half of Sxl
(exons 3 and 4), resulting in the construct hyb4. Vice versa, the
50 half of Sxl (exon 2) was fused to the 30 half of Ig-m (exons
C1–C4), giving the construct hyb3 (Figure 3A). HeLa cells
were stably transfected with PTC or PTC+ versions of
these fconstructs, and mRNA levels were determined from
Figure 2. Testing the ‘50 nucleotides boundary rule’ for NMD of Ig-m minigenes. (A) PTCs were introduced into exon C3 of the Ig-m minigene at the amino acid
positions indicated above the diagram. The numbers below depict the distance of these PTCs from the 30-most 50 splice site. The ‘50 nucleotides boundary’ is marked
by the dashed line. (B) RNA of polyclonal HeLa cell pools stably transfected with the indicated Ig-m minigenes under control of the human b-actin promotor were
analyzed by real-time RT–PCR. The indicated relative Ig-mmRNA levels were normalized to endogenous GAPDH mRNA. Average values of three real-time PCR
runs of a typical experiment are shown. Error bars indicate standard deviations. (C) Northern blot analysis of RNA harvested 48 h post transfection with a 32P-labeled
probe for Ig-m mRNA. As a loading control, the 18S rRNA band from the ethidium bromide-stained gel before blotting is shown in the lower panel. (D) RT–PCR
analysis of the RNA used in (B) to check for potential cryptic splicing between exon C3 and exon C4. Correct joining of exon C3 to exon C4 is predicted to give a PCR
product of 163 bp.
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polyclonal cell populations. When compared with the corre-
sponding PTC mRNA, PTC+ mRNA levels of hyb4 were
nearly as strongly downregulated as PTC+ mRNA of the
parental Ig-m minigene. In contrast, hyb3 mRNA was only
modestly downregulated (3-fold) in response to a PTC, simi-
lar to the Sxl minigene. This indicates that sequences in the 50
half of the Ig-m minigene, comprising VL and VDJ exons, are
necessary and sufficient to enhance downregulation of PTC+
mRNA 6-fold.
To more precisely map sequences responsible for efficient
NMD, we next deleted either the 50 half or the 30 half of the
VDJ exon in hyb4, giving rise to hyb8 and hyb6, respectively.
Because we wanted to avoid alteration of splicing, these
deletions did not include nucleotides close to the splice
sites. As shown in Figure 3A, PTC+ hyb6 mRNA was down-
regulated to the same extent as PTC+ mRNA of the parental
Ig-m minigene or hyb4, suggesting that the NMD-promoting
activity resides in the 50 half of the VDJ exon. Consistent with
this notion, deletion of the 50 half of the VDJ exon (hyb8)
resulted in loss of strong NMD. In fact, PTC+ hyb8 mRNA
was downregulated to almost exactly the same extent as hyb3
and the Sxl minigene, which both lack the Ig-m VDJ exon.
Northern blot analysis revealed one predominant band of the
expected size for all hybrid constructs (Figure 3B), suggesting
that none of the hybrid constructs induced any unpredicted
major alterations in splice site usage. Collectively, these
results demonstrate that a sequence of 177 bp, between
amino acid positions 19 and 76 of the VDJ exon, possesses
Figure 3. The 50 half of the Ig-m minigene VDJ exon is necessary for efficient NMD of Ig-m/Sxl hybrid transcripts. (A) Relative hybrid mRNA levels of HeLa cells
stably expressing the constructs schematically represented on the left were determined by real-time RT–PCR and are shown in the right panel. For each pair of hybrid
constructs, the PTCmRNA level (white bars) was set as 100% and the PTC+mRNA level (gray bars) was calculated relative to it. The hybrid mRNA values were
normalized to endogenous GAPDH mRNA. Average values of three real-time PCR runs of a typical cell pool are shown, and error bars indicate standard deviations. In
the left panel, exons originating from Ig-m are depicted in black and Sxl exons are depicted in gray. The position of the PTC is indicated by an asterisk and corresponds
to ter310 in minim or ter43 in Sxl, respectively. The white regions labeled withDmark deletions. (B) Northern blot analysis of 15mg of total cellular RNA isolated from
HeLa cells stably transfected with the indicated hybrid constructs. As a loading control, the 18S rRNA band from the ethidium bromide-stained gel before blotting is
shown in the lower panel.
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an NMD-enhancing activity that is necessary for the efficient
downregulation of hyb4.
Smaller deletions within the 50 half of the Ig-m VDJ exon
did not affect its NMD-promoting activity
Remarkably, the VDJ exons together with some immediately
flanking intronic sequences of two differently rearranged
TCR-b genes have recently been shown to possess a similar
downregulatory-promoting activity (19). Since genes of both
gene families more often than not acquire PTCs by the pro-
grammed DNA rearrangements during normal lymphocyte
development, it seemed reasonable to hypothesize that a com-
mon mechanism might have evolved to efficiently downregu-
late PTC+ TCR-b and immunoglobulin mRNA. A common
putative NMD-promoting factor could interact with the target
RNA either through a conserved sequence motif or through a
conserved secondary structure.
To search for conserved sequence motifs, we aligned the
rearranged VDJ exon sequences of several different TCR-b
and Ig-m genes. As expected for sequences encoding the vari-
able regions of their respective proteins, these sequences were
rather different and no highly conserved sequence motif was
detectable. Yet, we noticed some short stretches of higher
conservation in a region corresponding to amino acid positions
52–70 in our Ig-m gene (Figure 4A, underlined), which maps to
the 30 end of the 177 bp long NMD-promoting element (NPE).
However, deletion of these 57 bp from hyb4 and hyb6, giving
hyb9 and hyb10, respectively, did not affect the downregula-
tory activity of the VDJ sequences in the context of the Ig-m/
Sxl hybrid genes (Figure 4B, compare hyb4 with hyb9, and
hyb6 with hyb10).
Next, we applied the MFold program (28) to identify pre-
dicted secondary structures in the 50 half of the Ig-mVDJ exon.
A predicted stem–loop structure consisting of a 14 bp stem
with two single nucleotide bulges in the descending strand, a
CAG loop, and a DG of 20.6 kcal mole1 caught our atten-
tion (Figure 4C). This putative secondary structure is located
at the 50 end of the VDJ exon between amino acid 19 and
30, again within the 177 bp element that harbors the NMD-
promoting activity. However, no similar secondary structure
was predicted by MFold in the TCR-b VDJ exons studied by
Gudikote and Wilkinson (data not shown). Nevertheless, we
deleted the 33 bp comprising the predicted stem–loop in hyb4
and hyb6, giving hyb11 and hyb12, respectively, and deter-
mined the difference in steady-state mRNA from a PTC+ and
a PTC version of each hybrid construct transiently trans-
fected into HeLa cells. As shown in Figure 4D, deletion of the
predicted stem-loop sequence did not interfere with the NMD-
promoting activity of the VDJ sequences in the context of the
Ig-m/Sxl hybrid genes. Compared with the corresponding
PTC mRNA, PTC+ hyb11 mRNA and PTC+ hyb12
mRNA were downregulated to the same extent than PTC+
hyb4 mRNA and PTC+ hyb6 mRNA, respectively.
Since neither deletion of the 50-most 33 bp nor deletion of
57 bp in the 30 end of the NPE interfered with the activity of
this element, we next deleted the remaining 63 bp in the
middle of the NPE (amino acid positions 31–51) in hyb4
and in hyb6, giving hyb13 and hyb14, respectively.
Surprisingly, also this deletion did not interfere with the
NMD-promoting activity, and neither did the deletion
of the 18 bp comprising amino acid positions 71–76
(Figure 4D). Thus, we conclude that the NMD-promoting
activity exerted by the 50 half of the Ig-m VDJ exon must
consist of at least two redundant determinants.
The 50 half of the Ig-m VDJ exon is required for strong
downregulation of PTC+ Ig-m mRNA
The Ig-m/Sxl hybrid constructs allowed us to map an NMD-
promoting activity to the 50 half of the Ig-m VDJ exon. Next,
we asked whether this sequence element was also necessary
for efficient downregulation of mRNA expressed from
a PTC+ Ig-m minigene. To this end, the 177 bp long NPE
was deleted from the PTC-free and the ter310 version of the
Ig-m minigene, giving minimDNPE and minimDNPE+,
respectively. Figure 5A shows the relative Ig-m mRNA levels
in total RNA from polyclonal pools of HeLa cells stably
expressing the PTC or the PTC+ version of minimwt
and minimDNPE, respectively. As for the Ig-m/Sxl hybrid
transcripts (Figure 3), deletion of the NPE from minim results
in the loss of strong NMD: minimDNPE+ mRNA was only
3-fold reduced compared with minimDNPE, whereas the
PTC+ mRNA of the full-length minim is downregulated more
than 20-fold.
Next, we re-inserted into minimDNPE the NPE into the
C1 or the C3 exon in order to test if the NPE can also
function from a different position within the mRNA.
Although the PTC+ Ig-m mRNA levels appeared to be
reduced slightly more in these two constructs compared
with minimDNPE, downregulation of these PTC+ mRNAs
was still much less efficient than when the NPE is located in
its correct place in the 50-half of the VDJ exon (Figure 5A).
We conclude that NPE function is position-dependent and
that the NPE is inactive when placed in the constant region
of the Ig-m gene.
Finally, we wanted to know whether the NPE was required
for the reduced Ig-m mRNA levels observed in constructs with
a PTC downstream of the 50 nt boundary (Figure 2). There-
fore, we inserted into minimDNPE a PTC 31 (Ter452) or 10
nucleotides (Ter459) upstream of the 30-most 50 splice site and
measured the relative mRNA levels of these constructs stably
expressed in polyclonal HeLa cell pools. As shown in
Figure 5A, even in the absence of the NPE, Ter452 and
Ter459 still led to 5-fold reduced mRNA levels compared
with the PTC minimDNPE. Thus, violation of the 50 nt
boundary rule by PTC+ Ig-m transcripts does not require
the NPE.
To confirm that deletion of the NPE did not alter splicing
of the minimDNPE transcripts, we analyzed the PTC and
the PTC+ minimDNPE mRNA by northern blotting and
sequenced the cDNA region comprising Vleader, VDJ and C1
exons of minim and minimDNPE. Northern blotting gave a
single major band of the expected size for minim DNPE
mRNA (Figure 5B), and cDNA sequencing confirmed correct
splicing of the VDJ exon to its neighbouring exons (data not
shown). In addition, intactness of the ORF in the PTC
versions of minimDNPE, minimDNPE/NPEC1 and mini-
mDNPE/NPEC3 mRNA was confirmed by detecting the
Ig-m polypeptide by western blotting (Figure 5C). In accor-
dance with minimDNPE lacking 59 amino acids compared
with minimDNPE/NPEC1 and minimDNPE/NPEC3, the
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Figure 4. Smaller deletions within the 50 half of the Ig-m VDJ exon did not affect its NMD-promoting activity. (A) Alignment of VDJ exon sequences of several
different human and mouse Ig-m and TCR-b genes. ‘Minim’ is from the mouse Ig-m of the hybridoma cell line Sp6 (23). Accession numbers M13832 and M85255.1 are
rearranged VDJ regions of mouse and human Ig-m, respectively. Vb2 (accession no. X04331), Vb5.1 (19) and Vb8.1 (19) are mouse TCR-b sequences. The
underlined sequence corresponding to amino acid positions 52–70 in our Ig-mminigene contains conserved motifs and is deleted in hyb9 and hyb10. (B) Total cellular
RNA of HeLa cells transiently transfected with the indicated Ig-m/Sxl hybrid genes were analyzed 48 h post transfection by real-time RT–PCR. Relative Ig-mmRNA
levels were normalized to neomycin mRNA encoded on the transfected plasmid. Average values of three real-time PCR runs of a typical experiment are shown. Error
bars indicate standard deviations. (C) Predicted stem–loop structure located between amino acid positions 19 and 30 of Ig-m. (D) The 33 bp comprising the predicted
stem–loop structure depicted in (C) were deleted from hyb4 and hyb6, giving hyb11 and hyb12, respectively. The 63 bp between the predicted stem–loop and the
underlined motif in (A) were deleted from hyb4 and hyb6, giving hyb13 and hyb14, respectively. The 18 bp comprising amino acid positions 71–76 were deleted from
hyb4, giving hyb18. Transfection and real-time RT–PCR were as described in (B).
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polypeptide encoded by minimDNPE migrates slightly faster
than the two other polypeptides.
In summary, we conclude that the 177 bp long sequence in
the 50 half of the VDJ exon is a bona fide NMD-promoting
element that is required for efficient downregulation of PTC+
mRNA both in the heterologous context of the hybrid con-
structs as well as in the Ig-m minigene. Furthermore, we
showed that the NPE functions in a position-dependent manner
and that it is not required for NMD elicited by PTCs down-
stream of the 50 nt boundary.
DISCUSSION
The Ig-m minigene system described and analyzed here
behaves very similar to the parental, endogenous Ig-m gene
Figure 5. The NMD-promoting element is necessary for efficient NMD of Ig-m minigene mRNA and functions in a position-dependent manner. (A) Relative Ig-m
mRNA levels of HeLa cells stably expressing the constructs schematically represented on the left were determined by real-time RT–PCR and are shown in the right
panel. For all constructs, the PTCmRNA level (white bars) was set as 100% and the PTC+ (ter310) mRNA level (gray bars) was calculated relative to it. The Ig-m
values were normalized to endogenous GAPDH mRNA. Average values of three real-time PCR runs of one representative cell pool are shown, and error bars indicate
standard deviations. The deletion in all minimDNPE constructs, indicated by the white region marked with D, is identical to the deletion in hyb8 (Figure 3) and
comprises 177 bp from amino acid positions 19–76. MinimDNPE/NPEC1 and minimDNPE/NPEC3 were generated by insertion of the NPE into exon C1 or into exon
C3 of the PTC and the PTC+ version of minimDNPE, respectively. (B) Northern blot analysis of 15mg RNA from the PTC and PTC+minimDNPE expressing cells
analyzed in (A). As a loading control, the 18S rRNA band from the ethidium bromide-stained gel before blotting is shown in the lower panel. (C) Detection of the Ig-m
polypeptide in lysate of cells expressing the PTC version of the indicated constructs by western blotting confirms the intactness of the respective ORFs in these
mRNAs. MinimDNPE/NPEC1 and minimDNPE/NPEC3 encode for a 593 amino acids long polypeptide, the polypeptide encoded by minimDNPE is 59 amino
acids shorter.
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with respect to the relative abundance of mRNAs bearing
PTCs at different positions. Because the minigene was
expressed in HeLa cells under the control of the human
b-actin promoter, this result demonstrates that the major deter-
minants for the efficiency of PTC-mediated mRNA downre-
gulation reside within the mRNA sequence, and that the
position of the PTC within the mRNA is an important deter-
minant for the efficiency of NMD. Although similar observa-
tions were made previously for TCR-b minigenes (19), NMD
of b-globin was abrogated when the gene was expressed from
the thymidine kinase promoter of herpes simplex virus type
1 (29). Since NMD of neither Ig-m nor TCR-b genes expressed
from this viral promoter has been analyzed, we cannot exclude
that certain promoters could affect NMD efficiency of Ig-m
or TCR-b.
When we analyzed the extent of mRNA reduction caused by
PTCs at different positions in Ig-m, we found that downregula-
tion of the mRNA levels of both the endogenous gene and the
minigene gradually increased with increasing distance of the
PTC from the 50 end of the transcript until to the middle of the
VDJ exon (22,26,30). PTCs located downstream of this posi-
tion gave maximal downregulation (>20-fold). Interestingly,
the boundary for maximal downregulation appears to be
between amino acid positions 73 and 108, which overlaps
with the position where the V-segment was joined to the
D-segment during B-cell maturation (amino acid position
86/87). Since out-of-frame VDJ-rearrangements are the
major source for PTCs in immunoglobulins, it would make
sense that signals to ensure efficient downregulation of such
non-productively rearranged transcripts would have evolved
to act on PTCs downstream of the V–D junction. Possible
mechanisms by which the NMD-promoting sequence element
identified in this study might function to specifically enhance
downregulation of PTCs downstream of the V–D junction are
discussed below.
Alternatively, inefficient NMD of Ig-m mRNAs with PTCs
close to the 50 end could also result from translation re-
initiation at an in-frame start codon downstream of the
PTC, as was reported for TPI transcripts (8). For Ig-m
expressed in hybridoma cells, translation re-initiation has
also been reported to occur at codon 100 (Met100) with an
efficiency of 4% the normal rate when a PTC is located at
amino acid position 3 (30). However, translation re-initiation
at Met100 cannot readily explain why upstream PTCs at dif-
ferent positions cause a gradual 50-to-30 increase in mRNA
downregulation, ranging from 2-fold (Ter32) to 25-fold
(Ter73) for Ig-m minigenes, and from 2-fold (N89, ter3) to
10-fold (N114, ter73) for endogenous Ig-m genes (Figure 1).
Furthermore, we were not able to detect in Ter32, Ter57 or
Ter73-expressing cells an Ig-m polypeptide corresponding in
size to re-initiation at Met100, whereas we could detect this
polypeptide as reported previously (30) in N89, which we used
as our positive control (data not shown). Therefore, we favor
the hypothesis that the NPE identified in this study is fully
effective only when the PTC is located downstream of it, and
that its effect gradually decreases further upstream where a
PTC is located within the NPE.
According to the current models, NMD is triggered by an
interaction between a ribosome at the translation–termination
codon and components of the EJC, of which the 30-most is
located 22 nt upstream of the 30-most exon–exon junction (12).
Taking into account the sizes of the ribosome and the EJC, one
would predict that translation-termination codons <20–40 nt
upstream of the 30-most EJC should not trigger NMD. This
prediction is also supported by the empirically determined ‘50
nucleotides boundary rule’ (11). In partial agreement with this
prediction, PTC+ Ig-m mRNA levels increased 4- to 5-fold
when the PTC was located downstream of this boundary. But it
was unexpected that the PTCs located only 34 and 10 nt
upstream of the 30-most exon-exon junction still led to 3- to
5-fold reduced mRNA levels (Figure 2). This suggests that
either some PTC+ Ig-m mRNA downregulation occurs inde-
pendently of the EJC, or that additional EJC components bind
the Ig-m mRNA in the final exon. Importantly, PTCs in the
endogenous Ig-m gene behave very similar, based on Ig-m
mRNA quantifications in a large set of mutated Sp6 hybridoma
cell lines (31). In that study, Baumann and colleagues meas-
ured 3- to 10-fold reduced Ig-m mRNA levels in hybridoma
cells expressing Ig-m genes with PTCs located 10 nt upstream
of or across the 30-most exon-exon junction. As mentioned
earlier, in addition to Ig-m, TCR-b mRNAs with PTCs closer
than 50 nt to the 30-most exon–exon junction are also still
downregulated 2- to 5-fold compared with PTC- TCR-b
mRNA (20,21), suggesting that this ‘boundary-independent’
effect of PTCs might be part of the very efficient PTC+mRNA
downregulation response typical for genes belonging to the
immunoglobulin superfamily (see below). However, in con-
trast to the gradual decrease in NMD efficiency with decreas-
ing distance to the 30-most exon-exon junction reported for
TCR-b transcripts (21), NMD efficiency of Ig-m transcripts
appears to sharply decrease when the PTC is located beyond
the 50 nt boundary (Figure 2). This difference between TCR-b
and Ig-m might reflect a difference in the molecular mechan-
isms responsible for ‘Super-NMD’ of transcripts of these two
genes, but more work is required to clarify this point.
To identify cis-acting signals in Ig-m that are responsible for
the very strong NMD response, we have generated and ana-
lyzed a large set of hybrid PTC+ and PTC constructs com-
prising parts of the efficient NMD-substrate Ig-m and the poor
NMD-substrate Sxl (Figures 3 and 4). This approach led to the
identification of a 177 bp long sequence of Ig-m (amino acid
positions 19–76), essentially corresponding to the 50 half of the
VDJ exon, which is necessary (hyb8 and minim DNPE) and
sufficient (hyb6) to increase the NMD efficiency by a factor of
4- to 7-fold. Further support for the requirement of the NPE for
efficient NMD of Ig-m mRNAs comes from our analysis of an
alternatively spliced Ig-m transcript that is produced at very
low level (M.B€uhler and O.M€uhlemann, unpublished observa-
tion). This Ig-m alt-mRNA, resulting from joining the 50 splice
site of the leader exon to an alternative 30 splice site at amino
acid position 96 in the VDJ exon, lacks the NPE and generates
a frameshift that leads to a PTC further downstream in the
mRNA (data not shown). Interestingly in the context of the
study here, introduction of a frameshift mutation into the Ig-m
minigene (construct Ter108) that removes the PTC in
alt-mRNA results only in a moderate increase of alt-mRNA
between 1.6- and 3-fold (data not shown), which is similar to
the 3-fold reduction in mRNA caused by the PTC in hyb8 and
minim DNPE, but much less than the over 20-fold down-
regulation observed for NPE-containing mRNAs. We noticed
that all tested PTCs that elicit strong NMD are located
downstream of the NPE, which may indicate that the NPE
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can only promote NMD of PTCs located downstream of it (see
above). The fact that all tested partial deletions within the NPE
did not affect NMD efficiency suggests that this 177 bp long
sequence contains at least two separate, functionally redundant
motifs with NMD-promoting activity.
Since two different TCR-b VDJ exons (including immedi-
ately flanking intronic sequences) were also recently found to
promote PTC+ mRNA downregulation in a heterologous con-
text (19), it is tempting to speculate that a common mechanism
would function through conserved cis-acting signals in Ig-m
and TCR-b transcripts. However, except for a short sequence
with some conserved motifs (Figure 4A) that is dispensable for
NMD-promoting activity (Figure 4B), we could not detect any
conserved sequence motifs or predicted secondary structures.
Thus, we postulate that different RNA-binding factors with
different sequence-specificity can promote NMD by interact-
ing through a conserved domain with a common NMD factor.
Alternatively, interaction of a NMD-promoting trans-acting
factor with the transcript might be position-specific rather than
sequence-specific. Both explanations would be consistent with
the evidence for the existence of multiple different NMD-
promoting signals in the 50-half of the Ig-m VDJ exon, but
position-dependence alone cannot explain why such NMD-
promoting activities are only found in Ig-m and TCR-b
mRNA, but not in other transcripts investigated so far.
In the case of TCR-b, the downregulation-promoting VDJ
exon also functioned when placed between the C2.1 and the
C2.2 exon, provided that the PTC was located downstream of
it (19). In contrast, when we shifted the NPE of Ig-m and placed
it upstream (exon C1) or downstream (exon C3) of the PTC
(ter310 in exon C2), NPE activity was almost completely lost.
Thus, unlike TCR-b, the NPE identified in our Ig-m minigene
appears to function in a position-dependent manner.
Apart from the differences discussed above, obvious
similarities between TCR-b (19) and Ig-m (this study)
concerning the requirements for efficient NMD should also
be pointed out. In both genes, the NMD-promoting element
maps to the VDJ exon and appears to promote downregulation
of mRNAs only when the PTC is located downstream of the
element. Furthermore, TCR-b and Ig-m transcripts are to the
best of our knowledge the only known examples where PTCs
downstream of the ‘50 nucleotides boundary’ still cause a
reduction in steady-state mRNA levels (20,21), suggesting a
mode of PTC-mediated mRNA downregulation that is EJC-
independent. However, for both TCR-b and for Ig-m, this
downregulation of mRNAs with PTCs downstream of the
‘50 nucleotides boundary’ is significantly less efficient than
when the PTC is located upstream of the boundary. Based on
these observations, we propose that the highly efficient down-
regulation of PTC+ TCR-b and Ig-m mRNAs is the net result
of (i) ordinary EJC-dependent NMD plus (ii) an additional
PTC-specific process that recognizes PTCs independently of
their relative position to EJC. We provide here evidence that
the NPE of Ig-m enhances the efficiency of ordinary NMD, but
does not seem to influence the postulated additional, EJC-
independent process (see Figures 2B and 5A). The challenge
with this hypothesis of two distinct downregulatory processes
will be to explain how a PTC can be distinguished from the
physiological termination codon in the EJC-independent pro-
cess. In our future studies, we will also try to identify factors
that interact with the NMD-promoting element in order to gain
insight into the molecular mechanism by which this sequence
element contributes to the highly efficient downregulation of
PTC+ Ig-m mRNA levels.
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